|
|
|
|
|
The Niche Stem Cell & Regen Med Website
|
We have a new post today!
|
|
|
Weekly reads: MiMedX & Kimera Labs FDA warnings, NYT on Bryan Johnson, MUSE cell trial
|
|
|
|
Placental biologics firm MiMedx and exosome company Kimera Labs both recently received FDA warning letters. The letter to MiMedx was related to its placental biologics products and procedures. The new warning to Kimera Labs was about its exosome products and an amniotic product. Let's compare these letters starting with the one to MiMedX. MiMedx warning letter The FDA says in the …
|
|
|
|
|
|
|
